The outcome of COVID-19 in patients with hematological malignancy.
作者信息
Cakir Banu
机构信息
Hacettepe University Faculty of Medicine Department of Public Health, Sihhiye, Ankara, Turkey.
出版信息
J Med Virol. 2021 Mar;93(3):1229. doi: 10.1002/jmv.26576. Epub 2020 Oct 10.
Abstract
摘要
相似文献
1
The outcome of COVID-19 in patients with hematological malignancy.血液系统恶性肿瘤患者的新冠病毒病结局
J Med Virol. 2021 Mar;93(3):1229. doi: 10.1002/jmv.26576. Epub 2020 Oct 10.
2
Targeting human TLRs to combat COVID-19: A solution?靶向人类Toll样受体以对抗新冠病毒：一种解决方案？
J Med Virol. 2021 Feb;93(2):615-617. doi: 10.1002/jmv.26387. Epub 2020 Aug 13.
3
Concerns regarding calculation of fatality rate of Chinese samples in COVID-19 meta-analysis.关于新冠病毒荟萃分析中中国样本死亡率计算的担忧。
J Med Virol. 2020 Jul;92(7):710. doi: 10.1002/jmv.25799. Epub 2020 Apr 10.
4
Cofilin, an intracellular marker for HIV-associated CD4 T-cell motility dysregulation, shed light on the mechanisms of incomplete immune reconstitution in the patients with HIV.丝切蛋白是一种与HIV相关的CD4 T细胞运动失调的细胞内标志物，它为HIV患者免疫重建不完全的机制提供了线索。
J Med Virol. 2020 Jan;92(1):1-3. doi: 10.1002/jmv.25577. Epub 2019 Sep 9.
5
COVID-19 and seasonal influenza: a comparative analysis in patients with hematological malignancies.COVID-19 与季节性流感：血液系统恶性肿瘤患者的对比分析。
Leuk Lymphoma. 2022 Mar;63(3):664-671. doi: 10.1080/10428194.2021.1992626. Epub 2021 Oct 20.
6
The outcome ofancy. COVID-19 in patients with hematological malign.血液系统恶性肿瘤患者中新冠病毒病的结局。
J Med Virol. 2021 Mar;93(3):1255. doi: 10.1002/jmv.26607. Epub 2020 Nov 1.
7
Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies.土耳其血液系统恶性肿瘤患者 COVID-19 的临床特征和结局。
Turk J Haematol. 2022 Feb 23;39(1):43-54. doi: 10.4274/tjh.galenos.2021.2021.0287. Epub 2021 Sep 15.
8
SARS-CoV-2 infection and mortality in pediatric patients with hematological malignancies and solid tumors.血液系统恶性肿瘤和实体瘤儿科患者中的新型冠状病毒2型感染及死亡率
Pediatr Hematol Oncol. 2023 May;40(4):429-432. doi: 10.1080/08880018.2022.2120937. Epub 2022 Sep 12.
9
The outcome of COVID-19 in patients with hematological malignancy.COVID-19 患者的血液恶性肿瘤结局。
J Med Virol. 2021 Feb;93(2):1099-1104. doi: 10.1002/jmv.26404. Epub 2020 Aug 26.
10
Severe COVID-19 in patients with hematological cancers presenting with viremia.血液系统癌症患者出现病毒血症的重症 COVID-19。
Ann Oncol. 2021 Oct;32(10):1297-1300. doi: 10.1016/j.annonc.2021.07.002. Epub 2021 Jul 13.
本文引用的文献
1
The outcome of COVID-19 in patients with hematological malignancy.COVID-19 患者的血液恶性肿瘤结局。
J Med Virol. 2021 Feb;93(2):1099-1104. doi: 10.1002/jmv.26404. Epub 2020 Aug 26.
Zotero 插件